Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new publication reference has been added under Publications, citing a 2026 J Clin Oncol article about selpercatinib and postprogression therapies. This update enriches the study record with additional related literature tied to the trial.
    Difference
    0.0%
    Check dated 2026-05-25T14:32:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.3 to v3.5.4, reflecting a small maintenance update to the page metadata.
    Difference
    0.0%
    Check dated 2026-05-18T05:32:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The study location entry for Bucharest has been updated to use an alternate spelling/formatting (removing diacritics and standardizing the text). The page also reflects an updated revision/version label.
    Difference
    0.1%
    Check dated 2026-04-26T15:33:12.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Location name updated from Napoli, Campania, Italy, 80131 to Naples, Campania, Italy, 80131; page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T17:04:14.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T13:09:32.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    In Turkey, the study site list changed by removing Sarıyer and adding Yellowplace, both with postal code 34457.
    Difference
    0.0%
    Check dated 2026-02-28T06:32:35.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.